Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates.
about
Artemisinin combination therapy for vivax malariaEpidemiology of Plasmodium vivax Malaria in IndiaThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaResistance to therapies for infection by Plasmodium vivaxEvaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia.Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.Therapeutic efficacy of artemether-lumefantrine for Plasmodium vivax infections in a prospective study in Guyana.Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulationsPlasmodium vivax treatments: what are we looking for?Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported Plasmodium vivax in the State of Qatar.
P2860
Q24622539-A4A67E3F-DF47-4375-B842-4CCEC271DA7FQ28355353-0D646CA1-AEA5-4694-BBA1-E10030CCD7C4Q28478579-5E344228-6A68-488B-BE74-80F1E758FD06Q33481576-93AD8487-C00F-4670-9541-406FE0CA94D2Q33530920-1DD9D960-7294-4F07-9CBF-0557E8269670Q34259032-B0F6C6BE-5397-46AD-9528-7AC43A0E3E4EQ34452691-8FC95E0C-53F6-4405-889B-A61718DAB41EQ35207264-66559072-0B83-4E39-AEE0-99BED884F0C5Q35760893-5CADB4C6-D982-451D-B4F8-F0A7573DA563Q35768931-92494D05-80DD-446D-85C3-F2034EF70C4CQ35939302-ECDEC88B-32D0-4F3F-9B30-9796C4FBF16DQ36055608-517605EB-F19A-4CC6-8531-D9AE1A734BF4Q36667032-97F05D84-1E54-40C7-9E8A-5F131875191FQ39280389-4E5444C1-09D2-47AB-AF5F-7B6042E03CB9Q41911774-22714F40-5ECD-4ABF-8B84-13A227ADC081
P2860
Therapeutic responses of Plasmodium vivax and P. falciparum to chloroquine, in an area of western India where P. vivax predominates.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Therapeutic responses of Plasm ...... a where P. vivax predominates.
@en
type
label
Therapeutic responses of Plasm ...... a where P. vivax predominates.
@en
prefLabel
Therapeutic responses of Plasm ...... a where P. vivax predominates.
@en
P2093
P2860
P921
P356
P1476
Therapeutic responses of Plasm ...... ia where P. vivax predominates
@en
P2093
H C Srivastava
P K Mallick
P2860
P304
P356
10.1179/136485908X311759
P577
2008-09-01T00:00:00Z